Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review
- PMID: 21152980
- DOI: 10.1007/s11255-010-9879-4
Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review
Abstract
Evaluation of potential candidates for testosterone replacement therapy (TRT) includes a complete medical history, physical examination, and hormonal screening. The choice of testosterone assay is important in clinical decision making. TRT should, in theory, approximate natural endogenous production of the hormone. There is no apparent association between TRT and the development of prostate cancer. The administration of exogenous testosterone is not a means of reversing the aging process in men with normal testosterone levels, but it may offer considerable benefit for those with hypogonadism.
Similar articles
-
Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.Am J Mens Health. 2015 Jul;9(4):340-4. doi: 10.1177/1557988314540933. Epub 2014 Jun 26. Am J Mens Health. 2015. PMID: 24972716
-
Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.Postgrad Med. 2013 Mar;125(2):30-9. doi: 10.3810/pgm.2013.03.2639. Postgrad Med. 2013. PMID: 23816769
-
Testosterone Therapy: What We Have Learned From Trials.J Sex Med. 2020 Mar;17(3):447-460. doi: 10.1016/j.jsxm.2019.11.270. Epub 2020 Jan 9. J Sex Med. 2020. PMID: 31928918 Review.
-
Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.Int J Impot Res. 2019 Jan;31(1):25-30. doi: 10.1038/s41443-018-0065-z. Epub 2018 Aug 22. Int J Impot Res. 2019. PMID: 30135606
-
Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.Asian J Androl. 2011 Jul;13(4):563-8. doi: 10.1038/aja.2010.124. Epub 2011 May 16. Asian J Androl. 2011. PMID: 21572448 Free PMC article. Review.
Cited by
-
Changes in the levels of testosterone profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed by active surveillance.World J Urol. 2018 Aug;36(8):1209-1217. doi: 10.1007/s00345-018-2270-2. Epub 2018 Mar 20. World J Urol. 2018. PMID: 29560520
-
Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects.F S Rev. 2021 Jan;2(1):32-42. doi: 10.1016/j.xfnr.2020.11.001. Epub 2020 Nov 17. F S Rev. 2021. PMID: 33615283 Free PMC article.
-
Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes.J Urol. 2016 Oct;196(4):1082-9. doi: 10.1016/j.juro.2016.04.069. Epub 2016 Apr 27. J Urol. 2016. PMID: 27131465 Free PMC article.
-
Assessment of an ethanolic seed extract of Picralima nitida ([Stapf] Th. and H. Durand) on reproductive hormones and its safety for use.J Intercult Ethnopharmacol. 2015 Oct-Dec;4(4):293-301. doi: 10.5455/jice.20151030085004. Epub 2015 Nov 2. J Intercult Ethnopharmacol. 2015. PMID: 26649234 Free PMC article.
-
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.J Urol. 2013 Aug;190(2):639-44. doi: 10.1016/j.juro.2013.02.002. Epub 2013 Feb 8. J Urol. 2013. PMID: 23395803 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical